IP Library Granted Patent US 12,084,697
Granted Patent B2
US 12,084,697 · App. 18/158,339 · Granted Sep 10, 2024

Penicillin-G acylases

Inventors: Oscar Alvizo (Fremont, CA); David Elgart (San Mateo, CA); Robert Kevin Orr (Cranford, NJ); James Nicholas Riggins (San Francisco, CA); Anna Fryszkowska (New York, NY); Katrina W. Lexa (Santa Rosa, CA); Xiang Yi (San Carlos, CA); Da Duan (Foster City, CA); Courtney Dianne Moffett (San Francisco, CA); Nikki Dellas (San Carlos, CA); Vesna Mitchell (Santa Clara, CA)
Assignee: Codexis, Inc.
C12N9/84C07K14/62C12P21/02C12Y305/01011C07K2319/21
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,084,697
App. No.
18/158,339
Filed
Jan 23, 2023
Granted
Sep 10, 2024
Kind
B2
Art Unit
1651
USPC
435/68.1
Abstract

The present invention provides engineered penicillin G acylase (PGA) enzymes, polynucleotides encoding the enzymes, compositions comprising the enzymes, and methods of using the engineered PGA enzymes.

Claims (5)

1. An engineered polynucleotide sequence encoding an engineered penicillin G acylase capable of acylating insulin, wherein the polypeptide sequence of said penicillin G acylase is at least 98%, 99% or more identical to SEQ ID NO:100.

2. The engineered polynucleotide sequence of claim 1 , wherein said sequence comprises a polynucleotide sequence that is at least 98%, 99% or more identical to SEQ ID NO: 99.

3. A vector comprising the polynucleotide sequence of claim 2 .

4. The vector of claim 3 , further comprising at least one control sequence.

5. A host cell comprising the vector of claim 3 .